Temporal Cre‐mediated recombination exclusively in endothelial cells using Tie2 regulatory elements
- 6 August 2002
- Vol. 33 (4), 191-197
- https://doi.org/10.1002/gene.10117
Abstract
Summary: The versatility of the bacteriophage Cre/LoxP system is dependent on the availability of a spectrum of tissue‐specific Cre transgenic mice to address a host of biological questions. In this paper, we report on the generation of an inducible Tie2Cre transgenic mouse line that facilitates gene targeting exclusively in endothelial cells. The temporal manner of recombination is feasible through the use of a Cre‐estrogen receptor fusion protein ERT2 and was, in practical terms, achieved by feeding the animals the estrogen antagonist tamoxifen orally for 5 weeks. High efficiency of recombination was found in the vast majority of endothelial cell populations examined, as monitored by an EGFP reporter mouse line. Critically, no EGFP expression was observed in any uninduced mice. This inducible Cre line will be a very beneficial asset to investigating the role of endothelial specific genes in the adult mouse and to induce transgenes in the endothelium in an extremely efficient manner. genesis 33:191–197, 2002.Funding Information
- Deutsche Forschungsgemeinschaft (SFB 405)
- The VW Foundation (I/72-422)
- European Union QOL Program TAGAPO (QLG-CT-1999-00202)
This publication has 20 references indexed in Scilit:
- Site- and Time-Specific Gene Targeting in the MouseMethods, 2001
- Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in VivoDevelopmental Biology, 2001
- Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytesProceedings of the National Academy of Sciences, 2000
- Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinasesNucleic Acids Research, 1999
- Induction of the antigen receptor expression on Blymphocytes results in rapid competence for signaling of SLP-65 and SykThe EMBO Journal, 1998
- Regulation of Cre Recombinase Activity by Mutated Estrogen Receptor Ligand-Binding DomainsBiochemical and Biophysical Research Communications, 1997
- Regulation of Cre recombinase activity by the synthetic steroid RU 486Nucleic Acids Research, 1996
- Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase.Proceedings of the National Academy of Sciences, 1995
- Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targetingCell, 1993
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984